Alcon is one of the leading visioncare companies in the world, with a record of successful product development, and it will continue to launch technically superior products.
Spectacle lenses dominate Japan's myopia control market through cultural trust and accessibility, while multifocal and soft contact lenses gain tract ...
Optometrist, contact lens clinic supervisor at Aston University, and Alcon professional education faculty member, Hatim ...
Treatment options span corrective lenses, advanced control lenses (ortho-K, DIMS, HAL, multifocal contacts), and emerging pharmacological solutions like low-dose atropine, with Japan leading in ...
KeyBanc analyst Brett Fishbin raised the firm’s price target on Alcon (ALC) to $112 from $108 on higher multiple, while keeping an Overweight ...
I’ve been wearing contact lenses for over two decades; to find the best contact lenses for different vision needs, I tapped into my own experience and also relied on the expert insights of ...
Swiss eyecare firm Alcon said on Monday it has agreed to a deal worth a potential $430 million with US counterpart Lensar, ...
Alcon acquired a majority interest in Aurion Biotech, a clinical-stage company developing advanced cell therapies to treat eye diseases. Terms of the deal weren't disclosed.